Bulk Peptide Supply
10 mg vial
- Vendor score
- 84/100
- Effective vial price
- Not available
- Effective price per mg
- Not available
Humanin is a compound marketed around cellular aging or mitochondrial research.
Also known as humanin
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $2.16 | $4.43 | 2 | 2 | |
| $2.16 | $4.43 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $4.55 | 2 | 2 | |
| $2.40 | $6.70 | 3 | 3 | |
| $2.40 | $6.70 | 3 | 3 | |
| $2.40 | $6.70 | 3 | 3 | |
| $2.40 | $6.70 | 3 | 3 | |
| $2.40 | $6.70 | 3 | 3 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $6.70 | $8.25 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $8.20 | $9.00 | 2 | 2 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $6.48 | $7.42 | 3 | 5 | |
| $7.20 | $8.20 | 3 | 5 | |
| $7.20 | $8.20 | 3 | 5 | |
| $7.20 | $8.20 | 3 | 5 | |
| $7.20 | $8.20 | 3 | 5 | |
| $7.20 | $8.20 | 3 | 5 | |
| $7.20 | $8.05 | 2 | 4 | |
| $7.20 | $8.05 | 2 | 4 | |
| $7.20 | $8.05 | 2 | 4 | |
| $7.20 | $8.05 | 2 | 4 | |
| $7.20 | $8.05 | 2 | 4 | |
| $7.20 | $8.05 | 2 | 4 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 | |
| $7.20 | $7.90 | 1 | 3 |
Research shortlist · Sep 12, 2026
These research selections use the same basis: 10 mg vial. The selections remain from Sep 12, 2026; each price below comes from its dated market observation.
10 mg vial
10 mg vial
10 mg vial
What it is
suppresses neuronal cell death induced by the Swedish mutant of amyloid precursor protein; suppresses neuronal cell death induced by three different types of FAD genes and amyloid beta; amino acid sequence in first source. The listed molecular formula is C119H204N34O32S2. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
5 registered studies were found under this name in the current review. Each study still needs to be checked for the exact compound identity, population, endpoints, and results.
Search indexed research for this compound ↗Market context
Humanin is commonly sold or discussed for cellular aging, mitochondrial function, and longevity research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Same format. Same amount.
1 of 1 formats had a qualifying research shortlist on Sep 12, 2026. Vendor counts below reflect the available price observations.
Vendor directory
Grades describe the vendor record overall. They are not a test result for every product.
| Vendor | Grade | Compared offers | In stock when checked | Lowest effective package | Profile |
|---|---|---|---|---|---|
| Bulk Peptide SupplyVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| Peptide PartnersVendor grade | Grade B+ | Not available | Not available | Not availableNo market observation | View → |
| Oasis PeptidesVendor grade | Grade B+ | 1 | 1 | $103.28Automatic quantity percent off · listed $121.5010 mg vial · compare →Observed Sep 21, 2026 | View → |
| Core PeptidesVendor grade | Grade B+ | 1 | 1 | $14710 mg vial · compare →Observed Sep 21, 2026 | View → |
| Simple PeptideVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| RUOVendor grade | Grade B | Not available | Not available | Not availableNo market observation | View → |
| Premier Bio LabsVendor grade | Grade A- | 1 | 1 | $8510 mg vial · compare →Observed Sep 21, 2026 | View → |
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.